Cargando…

Benefits of Local Treatment Including External Radiotherapy for Hepatocellular Carcinoma with Portal Invasion

SIMPLE SUMMARY: The benefit of local treatment for hepatocellular carcinoma (HCC) with portal invasion is unclear. Radiotherapy can technically palliate vessel-invasive HCC; however, the survival benefit has not been confirmed. Local treatment including radiotherapy showed a survival benefit in larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Han Ah, Park, Sunmin, Seo, Yeon Seok, Yoon, Won Sup, Rim, Chai Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070697/ https://www.ncbi.nlm.nih.gov/pubmed/33919745 http://dx.doi.org/10.3390/biology10040326

Ejemplares similares

Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints
por: Park, Sunmin, et al.
Publicado: (2020)

Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis
por: Rim, Chai Hong, et al.
Publicado: (2021)

Salvage External Beam Radiotherapy after Incomplete Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review
por: Yang, Dae Sik, et al.
Publicado: (2021)

Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
por: Choe, Jung Wan, et al.
Publicado: (2022)

Where is clinical research for radiotherapy going? Cross-sectional comparison of past and contemporary phase III clinical trials
por: Park, Sunmin, et al.
Publicado: (2020)

The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies
por: Rim, Chai Hong, et al.
Publicado: (2018)

Dose-response relationship of stereotactic body radiotherapy for ultracentral tumor and comparison of efficacy with central tumor: a meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2020)

Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials
por: Rim, Chai Hong, et al.
Publicado: (2018)

Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review
por: Rim, Chai Hong, et al.
Publicado: (2020)

Role of local treatment including radiotherapy in Barcelona Clinic of Liver Cancer stage C patients: a nationwide cohort analysis in South Korea
por: Lee, Jeongshim, et al.
Publicado: (2019)

Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
por: Park, Sunmin, et al.
Publicado: (2021)

Variation of heart and lung radiation doses according to setup uncertainty in left breast cancer
por: Park, Sunmin, et al.
Publicado: (2021)

Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
por: Rim, Chai Hong, et al.
Publicado: (2021)

Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2023)

Clinical Impact of Supraclavicular Lymph Node Involvement of Stage IIIC Non-Small Cell Lung Cancer Patients
por: Park, Sunmin, et al.
Publicado: (2021)

Implications of Radiotherapy Utilization in Korea from 2010 to 2019
por: Lee, Jeongshim, et al.
Publicado: (2021)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2022)

Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma
por: Rim, Chai Hong
Publicado: (2021)

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019)

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines
por: Rim, Chai Hong, et al.
Publicado: (2016)

Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study
por: Pei, Youliang, et al.
Publicado: (2018)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
por: Beppu, Toru, et al.
Publicado: (2020)

Radiotherapy for pituitary adenomas: long-term outcome and complications
por: Rim, Chai Hong, et al.
Publicado: (2011)

Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma
por: Lee, Ju Hye, et al.
Publicado: (2014)

Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right Atrium
por: Lee, Han Ah, et al.
Publicado: (2020)

The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
por: Yeh, Shyh-An, et al.
Publicado: (2015)

External Beam Radiotherapy for Hepatocellular Carcinoma: a Review of the Current Guidelines in the East and the West
por: Yoon, Sang Min
Publicado: (2021)

A Simplified Technique of Percutaneous Hepatic Artery Port-Catheter Insertion for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Invasion
por: Choi, Sun Young, et al.
Publicado: (2010)

Benefits of adjuvant treatment including trastuzumab in HER2-positive pT1a-bN0M0 breast cancer: a systematic review and meta-analysis
por: Lee, Hye Yoon, et al.
Publicado: (2020)

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2023)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

The Benefits of Radical Treatments with Synchronous Splenectomy for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhang, Qikun, et al.
Publicado: (2022)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
por: Song, Xiaodong, et al.
Publicado: (2020)

Long Term Follow-up Results of External Beam Radiotherapy as Primary Treatment for Retinoblastoma
por: Choi, Sang Yul, et al.
Publicado: (2010)

Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15)
por: Choi, Seo Hee, et al.
Publicado: (2021)

Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion
por: Jue, Chen, et al.
Publicado: (2016)

Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma
por: Lee, Jieun, et al.
Publicado: (2012)

A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nfeomsn52cqu0toms9odir170n